A novel mutation in TAZ causes mitochondrial respiratory chain disorder without cardiomyopathy

Journal of Human Genetics volume 62, pages539–547(2017)Cite this article

Subjects

Abstract

Tafazzin, encoded by the TAZ gene, is a mitochondrial membrane-associated protein that remodels cardiolipin (CL), an important mitochondrial phospholipid. TAZ mutations are associated with Barth syndrome (BTHS). BTHS is an X-linked multisystemic disorder affecting usually male patients. Through sequence analysis of TAZ, we found one novel mutation c.39_60del p.(Pro14Alafs*19) by whole-exome sequencing and a reported missense mutation c.280C>T p.(Arg94Cys) by Sanger sequencing in two male patients (Pt1 and Pt2). Patient with c.280C>T mutation had dilated cardiomyopathy, while another patient with c.39_60del mutation had no feature of cardiomyopathy. A reported m.1555A>G homoplasmic variant was also identified in the patient having mutation c.39_60del by whole mitochondrial DNA sequencing method. This variant was not considered to be the main cause of mitochondrial dysfunction based on a cytoplasmic hybrid (cybrid) assay. Tafazzin expression was absent in both patient-derived fibroblast cells. Complementation of TAZ expression in fibroblasts from the patient with the novel mutation c.39_60del restored mitochondrial respiratory complex assembly. High-performance liquid chromatography–tandem mass spectrometry-based metabolic analysis revealed the decline of CL and the accumulation of monolysocardiolipin, indicating the loss of tafazzin activity. Owing to phenotypic variability, it is difficult to diagnose BTHS based on clinical features only. We conclude that genetic analysis should be performed to avoid underdiagnosis of this potentially life-threatening inborn error of metabolism.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

Rent or Buy

All prices are NET prices.

Figure 1
Figure 2
Figure 3

References

  1. 1

    Vreken, P., Valianpour, F., Nijtmans, L. G., Grivell, L. a, Plecko, B., Wanders, R. J. et al. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem. Biophys. Res. Commun. 279, 378–382 (2000).

    CAS  Article  Google Scholar 

  2. 2

    Johnston, J., Kelley, R. I., Feigenbaum, A, Cox, G. F., Iyer, G. S., Funanage, V. L. et al. Mutation characterization and genotype-phenotype correlation in Barth syndrome. Am. J. Hum. Genet. 61, 1053–1058 (1997).

    CAS  Article  Google Scholar 

  3. 3

    Gonzalez, I. L. Barth syndrome:TAZ gene mutations, mRNAs, and evolution. Am. J. Med. Genet. Part A 134A, 409–414 (2005).

    Article  Google Scholar 

  4. 4

    Aprikyan, A. A. & Khuchua, Z. Advances in the understanding of Barth syndrome. Br. J. Haematol. 161, 330–338 (2013).

    CAS  Article  Google Scholar 

  5. 5

    Sakamoto, O., Ohura, T., Katsushima, Y., Fujiwara, I., Ogawa, E., Miyabayashi, S. et al. A novel intronic mutation of the TAZ (G4.5) gene in a patient with Barth syndrome: creation of a 5′ splice donor site with variant GC consensus and elongation of the upstream exon. Hum. Genet. 109, 559–563 (2001).

    CAS  Article  Google Scholar 

  6. 6

    Ferri, L., Dionisi-Vici, C., Taurisano, R., Vaz, F. M., Guerrini, R. & Morrone, A. When silence is noise: infantile-onset Barth syndrome caused by a synonymous substitution affecting TAZ gene transcription. Clin. Genet. 90, 461–465 (2016).

    CAS  Article  Google Scholar 

  7. 7

    Jefferies, J. L. Barth syndrome. Am. J. Med. Genet. Part C Semin. Med. Genet. 163, 198–205 (2013).

    CAS  Article  Google Scholar 

  8. 8

    Barth, P. G., Valianpour, F., Bowen, V. M., Lam, J., Duran, M., Vaz, F. M. et al. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am. J. Med. Genet. 126A, 349–354 (2004).

    Article  Google Scholar 

  9. 9

    Roberts, A. E., Nixon, C., Steward, C. G., Gauvreau, K., Maisenbacher, M., Fletcher, M. et al. The Barth Syndrome Registry: distinguishing disease characteristics and growth data from a longitudinal study. Am. J. Med. Genet. A 158A, 2726–2732 (2012).

    Article  Google Scholar 

  10. 10

    Bowron, A., Honeychurch, J., Williams, M., Tsai-Goodman, B., Clayton, N., Jones, L. et al. Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype. J. Inherit. Metab. Dis. 38, 279–286 (2015).

    CAS  Article  Google Scholar 

  11. 11

    Ronvelia, D., Greenwood, J., Platt, J., Hakim, S. & Zaragoza, M. V. Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle. Mol. Genet. Metab. 107, 428–432 (2012).

    CAS  Article  Google Scholar 

  12. 12

    Moric-Janiszewska, E. & Markiewicz-Łoskot, G. Genetic heterogeneity of left-ventricular noncompaction cardiomyopathy. Clin. Cardiol. 31, 201–204 (2008).

    Article  Google Scholar 

  13. 13

    Chang, B., Momoi, N., Shan, L., Mitomo, M., Aoyagi, Y., Endo, K. et al. Gonadal mosaicism of a TAZ (G4.5) mutation in a Japanese family with Barth syndrome and left ventricular noncompaction. Mol. Genet. Metab. 100, 198–203 (2010).

    CAS  Article  Google Scholar 

  14. 14

    Cosson, L., Toutain, A., Simard, G., Kulik, W., Matyas, G., Guichet, A. et al. Barth syndrome in a female patient. Mol. Genet. Metab. 106, 115–120 (2012).

    CAS  Article  Google Scholar 

  15. 15

    Ferri, L., Donati, M. a, Funghini, S., Cavicchi, C., Pensato, V., Gellera, C. et al. Intra-individual plasticity of the TAZ gene leading to different heritable mutations in siblings with Barth syndrome. Eur. J. Hum. Genet. 23, 1708–1712 (2015).

    CAS  Article  Google Scholar 

  16. 16

    Rigaud, C., Lebre, A.-S., Touraine, R., Beaupain, B., Ottolenghi, C., Chabli, A. et al. Natural history of Barth syndrome: a national cohort study of 22 patients. Orphanet J. Rare Dis. 8, 70 (2013).

    Article  Google Scholar 

  17. 17

    Clarke, S. L. N., Bowron, A., Gonzalez, I. L., Groves, S. J., Newbury-Ecob, R., Clayton, N. et al. Barth syndrome. Orphanet J. Rare Dis. 8, 23 (2013).

    Article  Google Scholar 

  18. 18

    Ferri, L., Donati, M. A., Funghini, S., Malvagia, S., Catarzi, S., Lugli, L. et al. New clinical and molecular insights on Barth syndrome. Orphanet J. Rare Dis. 8, 27 (2013).

    Article  Google Scholar 

  19. 19

    Horvath, S. E. & Daum, G. Lipids of mitochondria. Prog. Lipid Res. 52, 590–614 (2013).

    CAS  Article  Google Scholar 

  20. 20

    Houtkooper, R. H., Turkenburg, M., Poll-The, B. T., Karall, D., Pérez-Cerdá, C., Morrone, A. et al. The enigmatic role of tafazzin in cardiolipin metabolism. Biochim. Biophys. Acta Biomembr. 1788, 2003–2014 (2009).

    CAS  Article  Google Scholar 

  21. 21

    Schlame, M., Ren, M., Xu, Y., Greenberg, M. L. & Haller, I. Molecular symmetry in mitochondrial cardiolipins. Chem. Phys. Lipids 138, 38–49 (2005).

    CAS  Article  Google Scholar 

  22. 22

    Houtkooper, R. H. & Vaz, F. M. Cardiolipin, the heart of mitochondrial metabolism. Cell Mol. Life Sci. 65, 2493–2506 (2008).

    CAS  Article  Google Scholar 

  23. 23

    Pfeiffer, K., Gohil, V., Stuart, R. a., Hunte, C., Brandt, U., Greenberg, M. L. et al. Cardiolipin stabilizes respiratory chain supercomplexes. J. Biol. Chem. 278, 52873–52880 (2003).

    CAS  Article  Google Scholar 

  24. 24

    Vaz, F. M., Houtkooper, R. H., Valianpour, F., Barth, P. G. & Wanders, R. J. A. Only one splice variant of the human TAZ gene encodes a functional protein with a role in cardiolipin metabolism. J. Biol. Chem. 278, 43089–43094 (2003).

    CAS  Article  Google Scholar 

  25. 25

    Kohda, M., Tokuzawa, Y., Kishita, Y., Nyuzuki, H., Moriyama, Y., Mizuno, Y. et al. A comprehensive genomic analysis reveals the genetic landscape of mitochondrial respiratory chain complex deficiencies. PLoS Genet. 12, e1005679 (2016).

    Article  Google Scholar 

  26. 26

    Hazkani-Covo, E., Zeller, R. M. & Martin, W. Molecular poltergeists: mitochondrial DNA copies (numts) in sequenced nuclear genomes. PLoS Genet. 6, e1000834 (2010).

    Article  Google Scholar 

  27. 27

    Hayashi, J., Ohta, S., Kikuchi, A., Takemitsu, M., Goto, Y. & Nonaka, I. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc. Natl Acad. Sci. USA 88, 10614–10618 (1991).

    CAS  Article  Google Scholar 

  28. 28

    Kulik, W., Van Lenthe, H., Stet, F. S., Houtkooper, R. H., Kemp, H., Stone, J. E. et al. Bloodspot assay using HPLC-tandem mass spectrometry for detection of barth syndrome. Clin. Chem. 54, 371–378 (2008).

    CAS  Article  Google Scholar 

  29. 29

    Mazurová, S., Tesařová, M., Magner, M., Houšťková, H., Hansíková, H., Augustínová, J. et al. Novel mutations in the TAZ gene in patients with Barth syndrome. Prague Med. Rep. 114, 139–153 (2013).

    Article  Google Scholar 

  30. 30

    Xu, Y., Malhotra, A., Claypool, S. M., Ren, M. & Schlame, M. Tafazzins from Drosophila and mammalian cells assemble in large protein complexes with a short half-life. Mitochondrion 21, 27–32 (2015).

    CAS  Article  Google Scholar 

  31. 31

    Joshi, A. S., Thompson, M. N., Fei, N., Ttemann, M. H. & Greenberg, M. L. Cardiolipin and mitochondrial phosphatidylethanolamine have overlapping functions in mitochondrial fusion in Saccharomyces cerevisiae. J. Biol. Chem. 287, 17589–17597 (2012).

    CAS  Article  Google Scholar 

  32. 32

    Spencer, C. T., Bryant, R. M., Day, J., Gonzalez, I. L., Colan, S. D., Thompson, W. R. et al. Cardiac and clinical phenotype in Barth syndrome. Pediatrics 118, e337–e346 (2006).

    Article  Google Scholar 

  33. 33

    Ren, M., Phoon, C. K. L. & Schlame, M. Metabolism and function of mitochondrial cardiolipin. Prog. Lipid Res. 55, 1–16 (2014).

    CAS  Article  Google Scholar 

  34. 34

    Schlame, M., Kelley, R. I., Feigenbaum, A., Towbin, J. a., Heerdt, P. M., Schieble, T. et al. Phospholipid abnormalities in children with Barth syndrome. J. Am. Coll. Cardiol. 42, 1994–1999 (2003).

    CAS  Article  Google Scholar 

  35. 35

    Coman, D., Yaplito-Lee, J. & Boneh, A. New indications and controversies in arginine therapy. Clin. Nutr. 27, 489–496 (2008).

    CAS  Article  Google Scholar 

  36. 36

    Kirwin, S. M., Manolakos, A., Barnett, S. S. & Gonzalez, I. L. Tafazzin splice variants and mutations in Barth syndrome. Mol. Genet. Metab. 111, 26–32 (2014).

    CAS  Article  Google Scholar 

  37. 37

    Gonzalvez, F., D’Aurelio, M., Boutant, M., Moustapha, A., Puech, J. P., Landes, T. et al. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation. Biochim. Biophys. Acta Mol. Basis Dis. 1832, 1194–1206 (2013).

    CAS  Article  Google Scholar 

  38. 38

    Schlame, M., Rua, D. & Greenberg, M. L. The biosynthesis and functional role of cardiolipin. Prog. Lipid Res. 39, 257–288 (2000).

    CAS  Article  Google Scholar 

  39. 39

    Acehan, D., Xu, Y., Stokes, D. L. & Schlame, M. Comparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomography. Lab. Invest. 87, 40–48 (2007).

    CAS  Article  Google Scholar 

  40. 40

    Acehan, D., Vaz, F., Houtkooper, R. H., James, J., Moore, V., Tokunaga, C. et al. Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome. J. Biol. Chem. 286, 899–908 (2011).

    CAS  Article  Google Scholar 

  41. 41

    Prezant, T. R., Agapian, J. V., Bohlman, M. C., Bu, X., Oztas, S., Qiu, W. Q. et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat. Genet. 4, 289–294 (1993).

    CAS  Article  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan to YO; the Support Project and a grant of Strategic Research Center in Private Universities from the MEXT, Japan to Saitama Medical University Research Center for Genomic Medicine. This work was also supported by Grants-in-Aid of the Research on Intractable Diseases (Mitochondrial Disorder) from the Ministry of Health, Labor and Welfare of Japan to KM. YO received a Special research grant from Takeda Science Foundation. NNB is a recipient of the Saitama Medical University Research Fellowship. We acknowledge the Laboratory Genetic Metabolic Disease in the Academic Medical Center in Amsterdam for measuring the MLCL/CL ratio. We thank Atsuko Imai for providing valuable comments. We are grateful to Ryoko Nakamura, Department of Pediatric Neurology, Fukuoka Children’s Hospital, Fukuoka, Japan; who is an attending physician of one of our patients.

Author contributions

NNB, YK and YO designed the study. NNB, YK and KI acquired data. KN, J-IH, YT, MK, HN, YY-S, KM and AO gave critical comments. YO, NNB and YK wrote the manuscript.

Author information

Affiliations

  1. Division of Functional Genomics & Systems Medicine, Research Center for Genomic Medicine, Saitama Medical University, Saitama, Japan

    Nurun N Borna, Yoshihito Kishita, Yoshimi Tokuzawa, Hiromi Nyuzuki, Yzumi Yamashita-Sugahara & Yasushi Okazaki

  2. Faculty of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Japan

    Kaori Ishikawa, Kazuto Nakada & Jun-Ichi Hayashi

  3. Division of Translational Research, Research Center for Genomic Medicine, Saitama Medical University, Saitama, Japan

    Masakazu Kohda & Yasushi Okazaki

  4. Department of Pediatrics, Obihiro Kosei General Hospital, Obihiro, Japan

    Takashi Nasu

  5. Department of Pediatrics, Hokkaido University Graduate School of Medicine, Hokkaido, Japan

    Atsuhito Takeda

  6. Department of Metabolism, Chiba Children’s Hospital, Chiba, Japan

    Kei Murayama

  7. Department of Pediatrics, Saitama Medical University, Saitama, Japan

    Akira Ohtake

Authors
  1. Nurun N Borna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshihito Kishita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kaori Ishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazuto Nakada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jun-Ichi Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoshimi Tokuzawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masakazu Kohda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiromi Nyuzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yzumi Yamashita-Sugahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Takashi Nasu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Atsuhito Takeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Kei Murayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Akira Ohtake
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Yasushi Okazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasushi Okazaki.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on Journal of Human Genetics website

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Borna, N., Kishita, Y., Ishikawa, K. et al. A novel mutation in TAZ causes mitochondrial respiratory chain disorder without cardiomyopathy. J Hum Genet 62, 539–547 (2017). https://doi.org/10.1038/jhg.2016.165

Download citation

Further reading

Search

Quick links